Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.
Sven SchneiderKatharina PoglitschChristina MorgensternTamara QuintKatharina GanglChristoph SinzTina BartosikNicholas James CampionDavid Tianxiang LiuLukas David LandeggerAldine TuVictoria StanekMarianne Rocha-HaslerChristine BangertJulia Eckl-DornaPublished in: The European respiratory journal (2023)
In this study, 57% of N-ERD patients tolerated higher doses of aspirin under dupilumab therapy.